
Funding
OpenScan Completes Series A Funding of 50 Million Yuan
Led by top medical investment funds with participation from renowned medical institutions, funds will accelerate product R&D and clinical application promotion.
3/20/2026
OpenScan Team
Stay updated with OpenScan news and industry insights

Led by top medical investment funds with participation from renowned medical institutions, funds will accelerate product R&D and clinical application promotion.

Both parties will jointly conduct clinical validation research on oncology AI decision support systems to promote the application of medical AI in clinical practice.

In-depth analysis of how Medical-RAG architecture achieves perfect fusion of medical rigor and AI capabilities, providing reference for the industry.